FIELD: medicine; pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical industry, namely to a method for increasing growth. Method of increasing height in a subject of child age suffering from cholestatic liver disease, comprising administering to the subject an effective amount of ASBTI, where ASBTI is
(maralixibate)
or a pharmaceutically acceptable alternative salt thereof, wherein ASBTI is administered in amount of 140 mcg/kg/day to 2000 mcg/kg/day.
EFFECT: use of the invention provides an increase in height in a child suffering from cholestatic liver disease.
35 cl, 36 dwg, 19 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRODUCING FUNCTIONAL PROTEIN FROM DNA HAVING NONSENSE MUTATIONS, AND TREATING ASSOCIATED DISORDERS | 2007 |
|
RU2462246C2 |
| DIHYDROPTERIDINONE DERIVATIVES AND USES THEREOF | 2015 |
|
RU2673944C2 |
| AMPK LOW-MOLECULAR ACTIVATORS | 2017 |
|
RU2766146C2 |
| ORGANIC COMPOUNDS | 2003 |
|
RU2478378C2 |
| CYANOTHIENOTRIAZOLODIAZEPINES AND METHODS FOR THEIR USE | 2016 |
|
RU2750164C2 |
| SYNERGISTIC COMBINATIONS OF AURISTANE | 2015 |
|
RU2717570C2 |
| APPLICATION OF S1P RECEPTOR AGONIST AND METHOD OF TREATMENT, ALLEVIATION OR RETARDATION OF OPTIC NEURITIS OR DEMYELINATING DISEASES PROGRESSION | 2003 |
|
RU2391094C2 |
| COMBINATION THERAPY WITH C-C CHEMOKINE RECEPTOR 9 (CCR9) INHIBITORS AND α4β7-INTEGRIN BLOCKING ANTIBODIES | 2015 |
|
RU2823984C2 |
| METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTIONS | 2012 |
|
RU2665021C2 |
| METHODS AND COMPOSITIONS TO IMPROVE COGNITIVE FUNCTIONS | 2012 |
|
RU2792010C2 |
